Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#3160 Efficacy and safety of PD-1 inhibitor combined with anlotinib in the treatment of advanced neuroendocrine cancer: A single-center retrospective study

Introduction: Neuroendocrine carcinoma is a group of poorly differentiated and highly malignant tumors. There is no standard follow-up treatment regimen after the failure of first-line treatment.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Song L, Yu X,

Keywords: immune checkpoint inhibitor, anlotinib, neuroendocrine carcinoma,

#3095 Clinical observation of PD-1 inhibitor combined with anlotinib in the treatment of advanced neuroendocrine carcinoma

Introduction: Clinical observation of PD-1 inhibitor combined with anlotinib in the treatment of advanced neuroendocrine carcinoma.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Song L, Yu X,

Keywords: immune checkpoint inhibitor, anlotinib, neuroendocrine carcinoma,

#1611 A Study of S1/Temozolomide (STEM) Regimen in Patients with Metastatic Neuroendocrine Tumors

Introduction: Both single agent Capecitabine alone or Capecitabine in combination with Temozolomide have activity against neuroendocrine tumors (NETs), however, the role of S-1 in NETs is still unknown.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Yihebali C, Jiuda Z, Yufeng W, Ba B, Liming J,

Keywords: Neuroendocrine tumors, Chemotherapy, S1,Temozolomide,